Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,811,974
  • Shares Outstanding, K 70,396
  • Annual Sales, $ 2,708 M
  • Annual Income, $ 247,100 K
  • EBIT $ 474 M
  • EBITDA $ 564 M
  • 60-Month Beta 1.42
  • Price/Sales 6.19
  • Price/Cash Flow 37.68
  • Price/Book 11.06

Options Overview Details

View History
  • Implied Volatility 40.17% (+3.84%)
  • Historical Volatility 31.14%
  • IV Percentile 57%
  • IV Rank 46.50%
  • IV High 60.02% on 04/10/25
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 8) 13.02 (5.43%)
  • Put/Call Vol Ratio 0.80
  • Today's Volume 36
  • Volume Avg (30-Day) 246
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 7,642
  • Open Int (30-Day) 7,564
  • Expected Range 226.63 to 252.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.15
  • Number of Estimates 9
  • High Estimate 1.29
  • Low Estimate 0.97
  • Prior Year 1.02
  • Growth Rate Est. (year over year) +12.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
233.29 +2.58%
on 03/06/26
275.10 -13.01%
on 02/18/26
-1.51 (-0.62%)
since 02/12/26
3-Month
233.29 +2.58%
on 03/06/26
299.80 -20.17%
on 01/07/26
-56.39 (-19.07%)
since 12/12/25
52-Week
233.29 +2.58%
on 03/06/26
354.88 -32.56%
on 11/20/25
-9.07 (-3.65%)
since 03/12/25

Most Recent Stories

More News
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Outcomes from EVOLUTION 2 study include 68% time in range with no boluses Diverse multicenter feasibility study highlights the promise...

PODD : 237.71 (-0.46%)
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence...

PODD : 237.71 (-0.46%)
1 Oversold Stock Set for a Comeback and 2 Facing Challenges

1 Oversold Stock Set for a Comeback and 2 Facing Challenges

SOUN : 7.60 (-2.44%)
MASI : 175.49 (+0.01%)
PODD : 237.71 (-0.46%)
PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance

PODD Q4 Deep Dive: Type 2 Diabetes Expansion and Innovation Drive Outperformance

PODD : 237.71 (-0.46%)
Stocks Settle Higher on Signs of US Economic Strength

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.56%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.80%. March E-mini...

AMAT : 339.57 (-3.28%)
B : 44.60 (-1.85%)
KNF : 79.86 (-0.21%)
HL : 20.70 (-2.13%)
GPN : 71.52 (-1.83%)
CDE : 21.78 (-2.64%)
ADI : 310.01 (-2.89%)
GLBE : 34.54 (+1.08%)
$IUXX : 24,648.54 (-1.27%)
ASML : 1,355.05 (-2.28%)
ZNM26 : 111-220 (-0.27%)
ESH26 : 6,709.00 (-1.04%)
Insulet (PODD) Shares Skyrocket, What You Need To Know

Insulet (PODD) Shares Skyrocket, What You Need To Know

PODD : 237.71 (-0.46%)
Stocks Rally on Signs of US Economic Resilience

The S&P 500 Index ($SPX ) (SPY ) today is up +0.84%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.20%. March E-mini S&P futures (ESH26...

AMAT : 339.57 (-3.28%)
B : 44.60 (-1.85%)
KNF : 79.86 (-0.21%)
HL : 20.70 (-2.13%)
GPN : 71.52 (-1.83%)
CDE : 21.78 (-2.64%)
ADI : 310.01 (-2.89%)
GLBE : 34.54 (+1.08%)
$IUXX : 24,648.54 (-1.27%)
ASML : 1,355.05 (-2.28%)
ZNM26 : 111-220 (-0.27%)
ESH26 : 6,709.00 (-1.04%)
Stocks Climb on Solid US Economic News and Easing AI Jitters

The S&P 500 Index ($SPX ) (SPY ) today is up +0.36%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.40%. March E-mini S&P futures (ESH26...

B : 44.60 (-1.85%)
KNF : 79.86 (-0.21%)
HL : 20.70 (-2.13%)
GPN : 71.52 (-1.83%)
CDE : 21.78 (-2.64%)
ADI : 310.01 (-2.89%)
DDOG : 128.74 (+0.98%)
GLBE : 34.54 (+1.08%)
$IUXX : 24,648.54 (-1.27%)
FIGR : 37.21 (-2.28%)
ZNM26 : 111-220 (-0.27%)
ESH26 : 6,709.00 (-1.04%)
Insulet: Q4 Earnings Snapshot

Insulet: Q4 Earnings Snapshot

PODD : 237.71 (-0.46%)
What Are Wall Street Analysts' Target Price for Insulet Stock?

Insulet has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

XLV : 150.94 (-1.25%)
$SPX : 6,706.24 (-1.03%)
PODD : 237.71 (-0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 244.91
2nd Resistance Point 241.95
1st Resistance Point 240.39
Last Price 237.71
1st Support Level 235.86
2nd Support Level 232.90
3rd Support Level 231.33

See More

52-Week High 354.88
Fibonacci 61.8% 308.43
Fibonacci 50% 294.08
Fibonacci 38.2% 279.74
Last Price 237.71
52-Week Low 233.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar